Momentum grows for hemophilia gene therapies | BioPharma Dive – BioPharma Dive
Investor’s Business Daily |
Momentum grows for hemophilia gene therapies | BioPharma Dive
BioPharma Dive An experimental gene therapy developed by BioMarin Pharmaceutical eliminated spontaneous bleeding and restored activity of a blood clotting protein to … BioMarin Stock Falls On Declining Gene-Therapy Impact On … |
